| Literature DB >> 23893127 |
Michaela S Tracy1, Shoshana M Rosenberg, Laura Dominici, Ann H Partridge.
Abstract
Recent studies have revealed increasing rates of contralateral prophylactic mastectomy (CPM) among women with unilateral early stage breast cancer. This trend has raised concerns, given the lack of evidence for a survival benefit from CPM and the relatively low risk of contralateral breast cancer for most women in this setting. In this article, we review available data regarding the value of CPM, predictors, and outcomes related to CPM, and areas for future research and potential intervention.Entities:
Mesh:
Year: 2013 PMID: 23893127 PMCID: PMC3860879 DOI: 10.1007/s10549-013-2643-6
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN: 0167-6806 Impact factor: 4.872